Crescita Therapeutics (CTX) Stock Price, News & Analysis

Company Overview

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

Key Stats

• Today's Range: C$0.79 to C$0.79
• 50-Day Range: C$0.79 to C$0.79
• 52-Week Range: C$0.40 to C$0.79
• Volume: 1,164 shs
• Average Volume: 42,290 shs
• Market Capitalization: C$14.71 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: TSE:CTX
• CIK: N/A
• Web: www.crescitatherapeutics.com
• Phone: +1-905-6734295
• Fax: N/A
• Employees: 62
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$2.61 million
• Net Margins: -1.38%
• Pretax Margin: N/A
• Return on Equity: -2.07%
• Return on Assets: -8.26%

Debt

• Debt-to-Equity Ratio: 17.34
• Current Ratio: 2.80
• Quick Ratio: 2.29

Sales & Book Value

• Annual Sales: C$23.22 million
• Price / Sales: 0.63
• Cash Flow: C$0.66 per share
• Price / Cash Flow: 1.20
• Book Value: C$0.77 per share
• Price / Book: 1.02

Miscellaneous

• Outstanding Shares: 18,614,000
• Free Float: N/A
• Market Cap: C$14.71 million
• Optionable: Not Optionable
• Beta: -1.55